Sunday, February 5, 2012
The Burrill Report (February 6, 2012): Fixing Drug Development with the Wisdom of Crowds
Download Now
|
|
Podcast Episode Summary
Transparency Life Sciences is betting on the wisdom of crowds when it comes to designing clinical trials. The company believes that it can address problems of falling R&D productivity that have plagued the pharmaceutical industry by using crowdsourcing and digital health technologies to design and conduct clinical trials more efficiently. We spoke to Tomasz Sablinski, CEO of Transparency, about what’s broken in drug development today, what his company is doing to change traditional approaches, and what needs to be done to prove Transparency's model works.
|
About Podcasts - RSS - The Burrill Report Podcast
More Science Podcasts
|